We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Italian Agency Hits Chinese Heparin Manufacturer for GMP Violations
Italian Agency Hits Chinese Heparin Manufacturer for GMP Violations
The Italian Medicines Agency found serious GMP violations during an Oct. 31 inspection of a heparin manufacturing facility in China and recommended that the firm be prohibited from supplying crude heparin sodium to the EU.